Jump Financial’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.3K Buy
+22,200
New +$22.1K ﹤0.01% 1952
2026
Q1
Sell
-10,631
Closed -$16.5K 2221
2025
Q4
$16.5K Buy
+10,631
New +$17K ﹤0.01% 1886
2022
Q1
Sell
-20,500
Closed -$209K 1777
2021
Q4
$209K Buy
+20,500
New +$220K 0.01% 1094

Other funds holding MXCT

Jump Financial's MXCT Position: Q2 2026 in Review

Jump Financial opened a new position in MaxCyte (MXCT) in Q2 2026: 22,200 shares worth $27.3K. The stake represents ﹤0.01% of the portfolio and ranks #1952 among its holdings. This is a return to the name: Jump Financial previously reported a position in MXCT as recently as Q4 2025.

Jump Financial first reported a position in MXCT in Q4 2021 and has held it in 3 quarters since. The position peaked at $209K in Q4 2021. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Jump Financial held 22,200 shares of MaxCyte worth $27.3K as of Q2 2026.
  • MaxCyte was a new Jump Financial position in Q2 2026.
  • MaxCyte made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1952 holding.
  • Jump Financial first reported a position in MaxCyte in Q4 2021 and has held it in 3 quarters since.
  • Jump Financial's MaxCyte position peaked at $209K in Q4 2021.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.